ELITE-2 end points
| End point | Number of patients | HR (95% CI) | p Value | ||||
|---|---|---|---|---|---|---|---|
| Losartan (n=1578) | Captopril (n=1574) | ||||||
| All cause mortality | 280 (17.7%) | 250 (15.9%) | 1.13 (0.95 to 1.35) | 0.16 | |||
| Sudden death or resuscitated cardiac arrest | 142 (9.0%) | 115 (7.3) | 1.25 (0.98 to 1.60) | 0.08 | |||
| Combined total mortality or hospitalisation for any reason | 752 (47.7%) | 707 (44.9%) | 1.07 (0.97 to 1.19) | 0.18 | |||
| Hospital admissions (all causes) | 659 (41.8%) | 638 (40.5%) | 1.04 (0.94 to 1.16) | 0.45 | |||
HR, hazard ratio; CI, confidence interval.